Nov 20: Chris Viehbacher of Sanofi-Aventis

Chris Viehbacher, chief executive of Sanofi-Aventis, reflects on his first year at the largest Eurozone pharma company. He discusses with Richard Milne, European business correspondent, the dominance of scientists, the dangers of acquisitions, and the benefits of emerging markets and US healthcare reform.